APOE and Alzheimer disease: Considering the frequency of the APOE ε4 allele among the human population (~14%) and late-onset familial AD (~40%),6,9APOE ε4 carriers with AD are worthy of consideration for special therapeutic diagnoses and interventions as a specific subtype of familial AD,6 such as the influence of the adaptive immunity evoked by HHV.